Turn Therapeutics

Turn Therapeutics

Growth Stage

A Revolution in Advanced Wound & Dermatology Care

A Revolution in Advanced Wound & Dermatology Care

Overview

Raised this Round: Raised: $406,564

Total Commitments ($USD)

Platform

StartEngine

Start Date

05/21/2024

Close Date

08/20/2024

Min. Goal
$14,991
Max. Goal
$1,234,995
Min. Investment

$248

Security Type

Equity - Common

Series

Series A

SEC Filing Type

RegCF    Open SEC Filing

Price Per Share

$9.18

Pre-Money Valuation

$122,527,672

Year Founded

2015

Industry

Healthcare & Pharmaceuticals

Tech Sector

HealthTech

Location

Westlake Village, California

Turn Therapeutics, with a valuation of $122.5 million, is raising funds on StartEngine. It is a pharmaceutical and medical device company known for its flagship formula, Hexagen. Turn Therapeutics’ formula targets dermatological ailments, including moderate to severe eczema and toenail fungus, and has FDA marketing approvals in advanced wound and dermatitis management. The company has also developed its PermaFusion technology by fusing oil and water-soluble active ingredients to revolutionize drug delivery. Bradley Burnam founded Turn Therapeutics in January 2015. The current crowdfunding campaign has a minimum target of $14,990.94 and a maximum target of $1.23 million. The campaign proceeds will be used for company employment, working capital, and research and development.

Summary Profit and Loss Statement

FY 2023 FY 2022

Revenue

$0

$0

COGS

$0

$0

Tax

$0

$0

 

 

Net Income

$-3,075,493

$-4,286,851

Summary Balance Sheet

FY 2023 FY 2022

Cash

$1,180,996

$2,102,983

Accounts Receivable

$0

$0

Total Assets

$1,931,541

$2,913,411

Short-Term Debt

$1,928,063

$1,724,014

Long-Term Debt

$0

$34,203

Total Liabilities

$1,928,063

$1,758,217

Financials as of: 05/21/2024
Create a free account today to gain access to KingsCrowd analytics.

Upgrade to gain access

Pay Monthly
Annually (Save 17%)

Edge

$25 /month
billed annually
Free portfolio tracking, data-driven ratings, AI analysis and reports
Plan Includes:
Everything in Free, plus
Company specific KingsCrowd ratings and analyst reports
Deal explorer and side-by-side comparison
Startup exit and failure tracking
Startup market filters and historical industry data
Advanced company search ( with ratings)
Get Edge Annual
Already a member? Log in here.
Founders: enhance your startup's credibility on KingsCrowd. Create an account to claim this raise page.
Add to portfolio
Turn Therapeutics on StartEngine 2024
Platform: StartEngine
Security Type: Equity - Common
Valuation: $122,527,672
Price per Share: $9.18

Follow company

Follow Turn Therapeutics on StartEngine 2024

Buy Turn Therapeutics's Deal Report

Turn Therapeutics Deal Report

Get KingsCrowd’s comprehensive report on Turn Therapeutics including:

  • How our proprietary algorithm rates their current capital raise (1-5 stars)
  • Detailed price, market, team, differentiators, performance, and risk ratings
  • Whether Turn Therapeutics is undervalued or overvalued
  • Scores on the founding team and key personnel's background and expertise

Buy the Turn Therapeutics deal report for only $10!

Email address:
Looking to buy more than one deal report? Get unlimited reports by upgrading to Edge